A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer
This study is looking at whether certain patients with early-stage breast cancer can safely skip radiation therapy after surgery without increasing the risk of the cancer coming back. By comparing hormone therapy alone to hormone therapy combined with radiation, researchers want to see if we can reduce unnecessary treatments while keeping patients healthy.
You might be eligible if you have early-stage, hormone-sensitive breast cancer that has been completely removed with clear edges during surgery. You should also be active, able to give consent, and have had your nearby lymph nodes checked.
Depending on which group you are placed in, you will either receive hormone-blocking medications alone or combined with radiation therapy. Your health team will closely monitor your recovery and check in on you regularly throughout the study.
This study is currently recruiting participants and is taking place at multiple medical locations, including sites in Alabama and Arizona. Your care team can help you find the most convenient location for your visits.
- 1Tests if radiation can be safely skipped after breast-conserving surgery for certain early-stage cancers.
- 2Compares hormone therapy alone against hormone therapy plus radiation.
- 3Currently recruiting participants at select locations in the United States.
Related video
Related links
Outside pages about this study, checked by our team
This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.